共 50 条
The First Successful Living Donor Liver Transplantation for Acute-on-Chronic Liver Failure Caused by Severe Acute Necrotizing Pancreatitis: A Case Report
被引:1
|作者:
Ishii, Masatsugu
[1
,2
]
Hirukawa, Kazuya
[1
]
Shimata, Keita
[1
]
Yoshimaru, Yoko
[3
]
Sagishima, Katsuyuki
[4
]
Sakurai, Yuto
[1
]
Tomita, Masahiro
[1
]
Isono, Kaori
[1
]
Honda, Masaki
[1
]
Sugawara, Yasuhiko
[1
]
Hirata, Naoyuki
[4
]
Tanaka, Yasuhito
[3
]
Hibi, Taizo
[1
,5
]
机构:
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Pediat Surg & Transplantat, Kumamoto, Japan
[2] Tochigi Canc Ctr, Dept Hepatobiliary Pancreat & Gastrointestinal Sur, Utsunomiya, Tochigi, Japan
[3] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol, Kumamoto, Japan
[4] Kumamoto Univ, Grad Sch Med Sci, Dept Anesthesiol, Kumamoto, Japan
[5] Kumamoto Univ, Kumamoto Univ Hosp, Transplantat Ctr, Grad Sch Med Sci,Dept Pediat Surg & Transplantat, 1-1-1 Honjo,Chuo ku, Kumamoto 8608556, Japan
关键词:
D O I:
10.1016/j.transproceed.2023.11.031
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Liver transplantation (LT) is the only life-saving option when acute-on-chronic liver failure (ACLF) does not improve with conservative therapy. Acute pancreatitis (AP) can cause chronic liver disease progression to ACLF. However, deceased donor LT for patients with AP has had mixed results, and no consensus has been established regarding the indication for LT. We report the first successful living donor LT (LDLT) for ACLF caused by severe AP. The 38-year-old patient with alcoholic liver disease was transferred to our institute with worsening refractory ascites. During the pretransplant workup, she developed severe acute necrotizing pancreatitis, resulting in grade 3 ACLF. The patient's clinical course was further complicated by high levels of donor-specific antibodies and immune thrombocytopenia. The AP gradually improved after intensive care combined with artificial liver support. The patient successfully underwent urgent LDLT with upfront splenectomy and desensitization therapy, including plasm exchange, highdose intravenous immunoglobulin, and anti-thymocyte globulin. No infection or recurrence of AP was observed postoperatively. We conclude that LDLT is a feasible option for ACLF patients caused by severe AP if a deceased donor is not readily available.
引用
收藏
页码:239 / 243
页数:5
相关论文